Menopausal Effects on Presentation, Treatment, and Survival of Women with Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 76, Issue 6, 2003, Pages 1789-1795

  Moore, Kimberly A ^b   Mery, Carlos M ^b   Jaklitsch, Michael T ^b   Estocin, Anastasia P ^b   Bueno, Raphael ^b   Swanson, Scott J ^b   Sugarbaker, David J ^b   Lukanich, Jeanne M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0345096419     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)01024-5     Document Type: Article

References (18)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001 - testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75;
3. quiz 77-80. Erratum in: CA Cancer J Clin 2001;51:150.
4. Rossing TH, Rossing R. Survival in lung cancer. An analysis of the effects of age, sex, resectability, and histopathologic type. Am Rev Respir Dis 1982;126:771-7.
5. Tiutiunova AM, Chirvina ED, Mironenko TV, Kartashov SZ, Luntovskaia VA. Hormonal balance in women with lung cancer and its changes after combined treatment. Vopr Onkol 1986;32(4):2-30.
6. Bouchardy C, Fioretta G, De Perrot M, Obradovic M, Spiliopoulos A. Determinants of long term survival after surgery for cancer of the lung: a population-based study. Cancer 1999;86:2229-37.
7. Ringbaek T, Borgeskov S, Lange P, Viskum K. Diagnostic and therapeutic process and prognosis in suspected lung cancer. Scand Cardiovasc J 1999;33:337-43.
8. De Perrot M, Licker M, Bouchardy C, Usel M, Robert J, Spiliopoulos A. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg 2000;119:21-6.
9. Huang C, Zhang X, Qiao Z, et al. Female lung cancer. Kyobu Geka 1995;48:95-9.
10. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340: 1801-11.
11. Canver CC, Memoli VA, Vanderveer PL, Dingivan CA, Mentzer RM Jr. Sex hormone receptors in NSCL in human beings. J Thorac Cardiovasc Surg 1994;108:153-7.
12. Lee TH, Chuang LY, Hung WC. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells. Oncogene 1999;18:4269-74.
13. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999;91:2032-8.
14. Rozenberg S, Liebens F, Kroll M, Vandromme J. Principal cancers among women: breast, lung, and colorectal. Int J Fertil Menopausal Stud 1996;41:166-71.
15. Tominaga K, Mori K, Yokoi K, et al. Lung cancer in patients under 50 years old. Jpn J Cancer Res 1999;90:490-5.
16. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44:833-9.
17. Ettinger B, Friedman GD, Bush T, Queensberry CP. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6-12.
18. Gadgeel SM, Severson RK, Kau Y, Graff J, Weiss LK, Kalemkerian GP. Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database. Chest 2001;120:55-63.